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Introduction
There is a clear, documented association between
Human Immunodeficiency Virus (HIV) and arthritis in
children and young people (CYP). However, this associa-
tion has not been clearly defined and the arthritis
has been seen to resolve with differing management
strategies.
Objectives
- To present a case of a child diagnosed and treated
for Juvenile Idiopathic Arthritis (JIA) who was subse-
quently found to have HIV which led to treatment
modification.
- To discuss HIV testing in CYP presenting with
arthritis.
- To explore appropriate treatment options in CYP
with HIV who have arthritis.
Methods
We retrospectively reviewed the case record of a four-
teen year old boy of African origin with arthritis. He
had been previously well and presented with a two week
history of initially right ankle swelling which progressed
to involve his left knee, right ankle, left wrist and distal
interphalangeal joint of his index finger of his left hand.
All these joints were swollen, warm and had restricted
range of movement. He was systemically well and was
diagnosed with polyarticular JIA. Initial management
consisted of oral Naproxen, Prednisolone 0.6 mg/kg and
Methotrexate 15 mg/m2.
This treatment resulted in some improvment in his
joint symptoms. However, he represented two weeks
later experiencing night sweats and was found to have
generalised lymphadenopathy. After further history and
investigation, he was diagnosed with HIV infection.
He was subsequently referred to tertiary centre specia-
lists in Paediatric Rheumatology and Infectious
Diseases/Immunology (at Sheffield Children’s Hospital)
for further investigation.
Results
His CD4 count was 295 × 106/L and viral load of 8487
copies/ml. Extensive investigation did not reveal another
infective cause for his joint symptoms. At presentation
his C reactive protein (CRP) was 18 mg/L and erythro-
cyte sedimentation rate (ESR) >145 mm/hr. Anti-nuclear
antibodies and extractable nuclear antigens were nega-
tive; double stranded DNA was 160 IU/ml.
Within a multidisciplinary team including specialists in
Infectious Diseases and Rheumatology, the current litera-
ture was reviewed. He was managed with intra-articular
administration of Triamcinolone Hexacetonide into
affected joints, and antiretroviral therapy. Two weeks
following this he was re-assessed showing complete reso-
lution of his joint signs and symptoms. Inflammatory
markers normalised with CRP <7 mg/L and ESR 5 mm/hr.
Conclusion
This case raises awareness of arthritis as a presenting
feature of HIV in CYP. Furthermore, it raises the ques-
tion of which CYP with JIA should be tested for HIV. It
also highlights that more international collaborative
work is required to determine optimal treatment strate-
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